Skip to main content
C

Carbometrics

Carbometrics develops a synthetic Glucose Binding Molecule (GBM) that offers highly selective glucose sensing through both optical and electrochemical signal coupling. This technology addresses the challenges of accurate glucose monitoring for individuals with diabetes, enhancing their ability to manage their condition effectively.

Bristol, United KingdomFounded 201817700+ followers
Updated 20 months ago

Funding

$13.8M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.

Funding rounds are not available yet.

Founders

Product

Problem

Current continuous glucose monitors (CGMs) can suffer from inaccuracies due to interference from other substances in the body, leading to unreliable readings and potentially impacting diabetes management. Achieving highly selective and stable glucose sensing remains a challenge for long-term implantable devices.

Solution

Carbometrics has developed a synthetic Glucose Binding Molecule (GBM) designed for highly selective glucose sensing in continuous glucose monitors. The GBM technology utilizes a biomimetic approach, featuring a 3D-scaffold optimized to bind specifically to glucose. This design minimizes interference from other compounds, enhancing the accuracy and reliability of glucose monitoring. The GBM is designed to be thermally, hydrolytically, and oxidatively stable, making it suitable for long-term use in implantable sensors.

Target Audience

The primary target audience includes manufacturers of continuous glucose monitors (CGMs) seeking to improve the accuracy, reliability, and longevity of their devices.

Features

  • Synthetic Glucose Binding Molecule (GBM) with a 3D-scaffold for selective glucose binding.
  • Demonstrated glucose sensing via both optical and electrochemical signals.
  • High selectivity for glucose, reducing potential interference from other substances.
  • Thermally and hydrolytically stable, enabling robust performance under varying conditions.
  • Oxidatively stable, making it suitable for long-term implantable applications.
  • Scalable production process, potentially leading to lower manufacturing costs.
This profile is AI-generated and may contain inaccuracies.